Reese Jan 4

What Happened

• Reese Jan, Chief Financial Officer of Trulieve Cannabis Corp. (TRUL), received equity awards on 2026-03-13: a grant of 58,594 restricted stock units (RSUs) and a derivative award covering 41,668 share-equivalents. The reported acquisition price for both awards is $0 (these are grants, not open-market purchases or sales).

Key Details

• Transaction date: 2026-03-13; Form 4 filed: 2026-03-17 (timely — within two business days).
• Reported consideration: $0 (grant/award).
• Vesting / exercisability:
  • RSUs (58,594): 50% vest on December 1, 2027; remaining 50% vest on December 1, 2028. (Footnote F1)
  • Derivative award (41,668): becomes exercisable/vests in three annual installments — one-third on Dec 1, 2026; one-third on Dec 1, 2027; one-third on Dec 1, 2028. (Footnote F2)
• Shares owned after transaction: not specified in the provided filing excerpt.
• Transaction code: A (award/grant); second award reported as a derivative instrument.
• Filing status: Timely (no late filing flag).

Context

• RSUs represent a contingent right to receive shares upon vesting; they do not represent immediately tradable stock until vested and settled.
• The derivative award appears to be an option-like instrument that becomes exercisable over three years; exercising would be a separate transaction and could produce Form 4 entries if shares are acquired or sold.
• These awards are compensation-related grants and are not direct indicators of buying or selling sentiment by the insider.